Assessment of Adherence to Treatment with Ethylmethylhydroxypyridine Malate in Patients with Chronic Cerebral Ischemia Using a Digital Platform

Abstract

Background. The problem of adherence to medical recommendations is always relevant. Low adherence or nonadherence to treatment has negative clinical and economic effects, such as influence on treatment success, prolongation of disease duration, increased risk of hospitalization, negative outcomes, and increased mortality risk. The aim of this study was to assess the impact of using the RX Observatory digital platform on adherence to treatment with Etoxydol (ethylmethylhydroxypyridine malate) in patients with chronic cerebral ischemia (CCI). Materials and methods. Medication adherence was studied in patients with CCI who visited doctors in three Moscow city polyclinics using the RX Observatory digital research platform and digital questionnaires. Results. The study found that 47% of patients fully adhered to the prescribed medication. Adherence was higher if the medication was prescribed by a medical specialist (general practitioner – 36 %, neurologist – 56 %), although adherence to medical recommendations was higher among patients visiting general practitioners (general practitioner – 48 %, neurologist – 43 %). Conclusions. The study showed that the RX Observatory platform may be a useful tool for developing medication adherence in patients taking Etoxydol (ethylmethylhydroxypyridine malate).